arrow_back Back Filing freshness 10-Q Q3 FY2025 SEC EDGAR

Bespoke Extracts, Inc.

BSPK
Price unavailable
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
60 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
51
Health
Fair
Neutral
auto_awesome

Analytical Summary

Bespoke Extracts, Inc. shows mixed fundamentals. On the positive side, Return on Common Equity (%) remains strong. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap
Dividend Yield
Revenue Growth 68.6%
Op. Margin -11.5%
ROIC 1.6%
FCF / Share $-0.00
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

60-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$467.94K
↑ +68.6%
Net Income Profit after all expenses
$-78.09K
↑ +71.7%
Operating Margin Operating profit as % of sales
-11.5%
↑ +72.2% 2th
FCF / Share Free cash flow per share
$-0.00
↑ +37.3%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
3
Returns
96
Cash Quality
56

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 60 quarters